- $85.90bn
- $101.52bn
- $25.51bn
- 34
- 27
- 52
- 31
Annual balance sheet for Medline, fiscal year end - December 31st, millions except per share.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | |
| Standards: | — | USG | USG |
| Status: | fx Preliminary | Final | Final |
| Cash and Equivalents | |||
| Cash and Short Term Investments | — | 1,556 | 199 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | — | 2,960 | 3,219 |
| Total Inventory | |||
| Total Other Current Assets | |||
| Total Current Assets | — | 8,809 | 8,272 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | — | 4,797 | 4,979 |
| Net Goodwill | |||
| Net Intangible Assets | |||
| Other Long Term Assets | |||
| Total Assets | — | 36,122 | 35,978 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | — | 2,131 | 2,440 |
| Long Term Debt | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Funded Status | |||
| Total Liabilities | — | 19,145 | 19,454 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Other Equity | |||
| Total Equity | — | 16,977 | 16,524 |
| Total Liabilities & Shareholders' Equity | — | 36,122 | 35,978 |
| Total Common Shares Outstanding |